Benefits of Organic Sacha Inchi Oil:
Omega-3 and 9
-Reduces three highs (hypertension , hyperlipidemia , hyperglycemia )
-Improve cardiovascular (heart and blood vessel diseases) , reduce the risk of stroke and Alzheimer’s
-Promotes metabolism, help lose weight and gain muscle (stimulate insulin sensitivity)
-Improves sleeping quality
-Maintains skin elasticity, lock in moisture on the skin surface and smooth the skin
-Helps in lowering lipids and improving insulin sensitivity 
-Strengthens the body’s immunity
-Regulates hormone levels
-Promotes cell renewal (for example, repair sunburned skin)
-Maintains bone health
-Helps wound healing and prevents heavy bleeding
-May helps in cardiovascular health 
-May helps in decreasing the risk of getting Type 2 Diabetes 
-Effective fat-soluble antioxidant
-Help to clear excessive free radicals to prevent too much oxidation happens in your body
-Easy way to prevent heart disease 
-Increased Energy To The Heart
-Improves and strengthens the cardiovascular system
– Prevent heart failure 
-Helps maintain normal blood pressure
– Reduce the incidence of stroke 
-Promotes energy production of body cells.
-Improves human immunity, enhance anti-oxidation, delay aging and enhance human vitality
-Potential in reducing migraine problem 
Suitable for all ages adults. High cholesterol, high blood pressure, high blood sugar, heart disease, obese people and vegetarians
Sacha inchi oil
Way of eating
Take 1-2 capsules a day after meals
60 vegetable softgels x 500MG
-Product liability insurance up to 1 million
 A. E. Naini, N. Keyvandarian, M. Mortazavi, S. Taheri, and S. M. Hosseini, “Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients,” J. Res. Pharm. Pract., vol. 4, no. 3, p. 135, 2015, doi: 10.4103/2279-042X.162356.
 A. AN, O. Á. JG, and E. J. I, “Metabolic status is related to the effects of adding of sacha inchi (Plukenetia volubilis L.) oil on postprandial inflammation and lipid profile: Randomized, crossover clinical trial,” J. Food Biochem., vol. 43, no. 2, Feb. 2019, doi: 10.1111/JFBC.12703.
 A. N. Alayón, J. G. Ortega Avila, I. Echeverri Jimenez, and I. Echeverri Jiménez, “Carbohydrate metabolism and gene expression of sirtuin in healthy subjects after Sacha Inchi supplementation: A randomized trial,” no. 3, Mar. 2013, doi: 10.1039/C7FO01956D.
 S. U. Khan et al., “Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis,” EClinicalMedicine, vol. 000, p. 100997, 2021, doi: 10.1016/j.eclinm.2021.100997.
 K. C. Maki, F. Eren, M. E. Cassens, M. R. Dicklin, and M. H. Davidson, “ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps,” Adv. Nutr., vol. 9, no. 6, pp. 688–700, 2018, doi: 10.1093/advances/nmy038.
 S. MK et al., “Vitamin K supplementation and progression of coronary artery calcium in older men and women,” Am. J. Clin. Nutr., vol. 89, no. 6, pp. 1799–1807, Jan. 2009, doi: 10.3945/AJCN.2008.27338.
 J. W. J. Beulens, D. L. van der A, D. E. Grobbee, I. Sluijs, A. M. W. Spijkerman, and Y. T. van der Schouw, “Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 Diabetes,” Diabetes Care, vol. 33, no. 8, pp. 1699–1705, Aug. 2010, doi: 10.2337/DC09-2302.
 E. B. Rimm, M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett, “Vitamin E Consumption and the Risk of Coronary Heart Disease in Men,” http://dx.doi.org/10.1056/NEJM199305203282004, vol. 328, no. 20, pp. 1450–1456, Jan. 2010, doi: 10.1056/NEJM199305203282004.
 M. J. Stampfer, C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett, “Vitamin E Consumption and the Risk of Coronary Disease in Women,” http://dx.doi.org/10.1056/NEJM199305203282003, vol. 328, no. 20, pp. 1444–1449, Jan. 2010, doi: 10.1056/NEJM199305203282003.
 I. P. de Barcelos and R. H. Haas, “CoQ10 and Aging,” Biology (Basel)., vol. 8, no. 2, Jun. 2019, doi: 10.3390/BIOLOGY8020028.
 J. J. DiNicolantonio, J. Bhutani, M. F. McCarty, and J. H. O’Keefe, “Coenzyme Q10 for the treatment of heart failure: a review of the literature,” Open Hear., vol. 2, no. 1, p. e000326, Oct. 2015, doi: 10.1136/OPENHRT-2015-000326.
 A. Martelli, L. Testai, A. Colletti, and A. F. G. Cicero, “Coenzyme Q10: Clinical Applications in Cardiovascular Diseases,” Antioxidants, vol. 9, no. 4, Apr. 2020, doi: 10.3390/ANTIOX9040341.
 S. L et al., “Serum Coenzyme Q10 Is Associated with Clinical Neurological Outcomes in Acute Stroke Patients,” J. Mol. Neurosci., vol. 66, no. 1, pp. 53–58, Sep. 2018, doi: 10.1007/S12031-018-1115-1.
 S. PS et al., “Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial,” Neurology, vol. 64, no. 4, pp. 713–715, Feb. 2005, doi: 10.1212/01.WNL.0000151975.03598.ED.